Susan L. Solomon is Founder and Chief Executive Officer of The New York Stem Cell Foundation (NYSCF) Research Institute, the world’s leading non-profit research institute dedicated to translating cutting-edge stem cell research into clinical breakthroughs. Privately funded, NYSCF is unconstrained and therefore unique in its ability to expedite the most promising stem cell research both at its own independent laboratory employing 45 full-time scientists and through its collaborations with more than 50 academic, philanthropic, and corporate institutions around the globe. From a standing start in 2005—only 10 years ago—NYSCF has raised and invested more than $150 million in “tipping point” stem cell research, accelerating progress in finding treatments and cures for diabetes, ALS, multiple sclerosis, Parkinson’s, Alzheimer’s, heart disease, cancer, schizophrenia, macular degeneration, and bone degeneration, among other diseases.
A veteran healthcare advocate, Ms. Solomon serves on the boards of a number of prominent diabetes and regenerative medicine organization including the College Diabetes Network and the Centre for Commercialization of Regenerative Medicine. She has received numerous awards for her work with NYSCF, including the New York State Women of Excellence Award from the Governor of New York, the Triumph Award from the Brooke Ellison Foundation, and recognition as a Living Landmark from the New York Landmarks Conservancy.
A lawyer by training and a chief executive and entrepreneur by experience, Susan L. Solomon brings decades of leadership experience in starting and building effective and focused organizations. Ms. Solomon started her career as an attorney at Debevoise & Plimpton, then held executive positions at MacAndrews and Forbes and APAX (formerly MMG Patricof and Co.). She was the founder and President of Sony Worldwide Networks, the Chairman and CEO of Lancit Media Productions, an Emmy award-winning television production company, and then served as the founding CEO of Sothebys.com, prior to starting her own strategic management consulting firm Solomon Partners LLC in 2000.
She received her BA cum laude from New York University and her JD from Rutgers University School of Law, where she was as an editor of the Law Review.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.